Clinical Trials Directory

Trials / Completed

CompletedNCT00852514

The Optimization of Blood Pressure and Fluid Status Control With Eight-Polar Bioelectrical Impedance Analysis

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
132 (actual)
Sponsor
Taipei Veterans General Hospital, Taiwan · Other Government
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Peritoneal dialysis (PD) is a widely used modality of renal replacement therapy. Due to its continuous nature of therapy, better control of fluid status and preservation of residual renal function were presumed by most nephrologists. However, recent evidences showed that it might not be the case. The severity of fluid overloading and the need for anti-hypertensive agents to control blood pressure seems to be more severe for PD patients. Therefore, more aggressive strategy to control dry weight is mandatory in PD patients. However, over reduction of dry weight might affect residual renal function (RRF) and, probably, the survival of PD patients. A balance between reduction of dry weight and preservation of RRF is crucial for the care of PD patients. Currently, only clinical measures like cardiothoracic ratio on chest X-ray and absence of pedal edema were used to evaluate PD patient's dry weight. There is no objective method to determine dry weight accurately. In this prospective and randomized study, the investigators will use multi-frequency bio-impedance (MF-BIA) to detect intracellular and extracellular water (ECW) content of patients.

Conditions

Interventions

TypeNameDescription
DEVICEBioelectrical impedance-guide dry weight reductionfor optimal determination of fluid status, monthly BIA was performed to monitor fluid status and avoid dehydration

Timeline

Start date
2006-09-01
Primary completion
2007-09-01
Completion
2007-09-01
First posted
2009-02-27
Last updated
2009-02-27

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT00852514. Inclusion in this directory is not an endorsement.